{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomics in Chronic Lymphocytic Leukemia: Current Research & Future Implications

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide information on the use of genomics in the treatment and understanding of chronic lymphocytic leukemia (CLL).

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize various somatic mutations that work together to generate the CLL phenotype.
  2. Identify promising treatment strategies targeting specific genomic profiles for CLL.

Disclosures

The authors, faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OT0218
Published: Feb 2018
Expires: 1/1/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Brandon May
Categories: Oncology
Specialties: Oncology
Topics: Chronic Lymphocytic Leukemia (CLL) , Genomics